Shire has issued a voluntary recall of 39 lots of Daytrana (methylphenidate) transdermal patches because of difficulties removing the release liner. This recall is not due to safety issues.  All Daytrana patches, including those in the recalled lots, can continue to be used unless the release liner cannot be removed, or the patches are damaged while being opened.

Daytrana is indicated for the treatment of attention deficit hyperactivity disorder (ADHD).

For more information call (800) 828-2088 or visit www.Daytrana.com.